Nonpharmacological therapies for sleep disturbances in Parkinson’s disease patients: A Systematic review
Objective: To systematically review and examine the effectiveness of nonpharmacological therapies that helpful to sleep disturbances for patients with Parkinson’s disease (PD). Background: Sleep disturbances…Sleep quality in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel infusion
Objective: To describe the effects of levodopa/carbidopa intestinal gel (LCIG) infusion on sleep quality in patients with advanced Parkinson's disease (PD). Background: Worsening of sleep…Quantitative demonstration of the efficacy of rotigotine transdermal patch in the treatment of nocturnal hypokinesia: A randomized, placebo-controlled trial using an axial inertial sensor
Objective: To evaluate the efficacy of rotigotine transdermal patch, using a wearable sensor, to treat PD patients with nocturnal immobility. Background: Nocturnal hypokinesia is a…A computerized cognitive behavioral therapy randomized, controlled, pilot trial for insomnia in Parkinson’s disease (The ACCORD-PD study)
Objective: To demonstrate benefit of computerized cognitive behavioral therapy for insomnia (CCBT-I) in Parkinson's disease (PD) patients. We are unaware of any study on CCBT-I…Rasagiline treatment for sleep disorders in Parkinson’s disease (RaSPar) – Double-blinded, randomized, placebo-controlled, placebo run-in-phase, polysomnography clinical trial
Objective: To study the effects of Rasagiline on sleep disturbances measured by polysomnographic (PSG) evaluation of sleep efficacy and secondary measures as other sleep variables,…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.